Institutional investors purchased a net $2.1 million shares of IMMU during the quarter ended December 2013, and now own 40.48% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SUSQUEHANNA FINANCIAL GROUP LLLP Bought 313.8 Thousand shares of Immunomedics Inc